|
Market Closed -
Canadian Securities Exchange
07:44:09 26/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.005000 CAD | 0.00% |
|
0.00% | -91.67% |
Company Valuation: RAMM Pharma Corp.
Data adjusted to current consolidation scope
| Fiscal Period: October | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 54.85 | 57.4 | 24.48 | 5.969 | 1.194 | 1.791 |
| Change | - | 4.66% | -57.35% | -75.61% | -80% | 50% |
| Enterprise Value (EV) 1 | 26.94 | 40.28 | 15.39 | 1.258 | 0.5682 | 1.067 |
| Change | - | 49.51% | -61.79% | -91.83% | -54.83% | 87.86% |
| P/E | -7.44x | -7.1x | -1.17x | -0.78x | -0.07x | -0.2x |
| PBR | 1.53x | 1.02x | 0.69x | 0.2x | 0.09x | 0.31x |
| PEG | - | 0.6x | -0x | 0x | -0x | 0x |
| Capitalization / Revenue | 10.1x | 13.9x | 6.28x | 1.18x | 0.27x | 0.53x |
| EV / Revenue | 4.95x | 9.79x | 3.95x | 0.25x | 0.13x | 0.32x |
| EV / EBITDA | -3.72x | -6.71x | -2.2x | -0.21x | -0.07x | -0.27x |
| EV / EBIT | -3.56x | -6.06x | -1.94x | -0.18x | -0.06x | -0.24x |
| EV / FCF | -14.3x | -8.01x | -4.06x | -0.54x | -0.2x | 1.04x |
| FCF Yield | -6.98% | -12.5% | -24.7% | -184% | -504% | 96.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0739 | -0.0655 | -0.1707 | -0.0638 | -0.1382 | -0.0746 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 5.445 | 4.116 | 3.897 | 5.065 | 4.342 | 3.361 |
| EBITDA 1 | -7.235 | -6.007 | -7.003 | -6.037 | -7.967 | -3.929 |
| EBIT 1 | -7.576 | -6.642 | -7.937 | -7.086 | -8.938 | -4.531 |
| Net income 1 | -7.431 | -7.107 | -20.96 | -7.721 | -16.5 | -8.91 |
| Net Debt 1 | -27.91 | -17.12 | -9.09 | -4.712 | -0.6257 | -0.7235 |
| Reference price 2 | 0.550000 | 0.465000 | 0.200000 | 0.050000 | 0.010000 | 0.015000 |
| Nbr of stocks (in thousands) | 99,723 | 1,23,449 | 1,22,400 | 1,19,389 | 1,19,389 | 1,19,389 |
| Announcement Date | 01/03/21 | 22/03/22 | 28/02/23 | 29/02/24 | 04/03/25 | 05/03/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 4L | |
| 37.84x | 13.27x | 28.43x | 0.53% | 1,14800Cr | |
| 39.67x | 6.67x | 18.75x | 1.97% | 65TCr | |
| 37.4x | 8.39x | 17.35x | 2.4% | 51TCr | |
| 21.45x | 5.21x | 12.93x | 2.51% | 38TCr | |
| 102.73x | 5.76x | 24.72x | 2.42% | 35TCr | |
| 21.89x | 5.76x | 13.88x | 2.85% | 29TCr | |
| 22.21x | 4.49x | 12.82x | 1.97% | 26TCr | |
| 28.66x | 7.33x | 13.12x | 2.23% | 24TCr | |
| -45.79x | 7.11x | 27.55x | 2.07% | 20TCr | |
| Average | 29.56x | 7.11x | 18.84x | 2.11% | 40.37TCr | |
| Weighted average by Cap. | 35.29x | 8.40x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RAMM Stock
- Valuation RAMM Pharma Corp.
Select your edition
All financial news and data tailored to specific country editions
